These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 32816293)

  • 1. [Psychedelics in the treatment of substance use disorders and psychosis].
    van den Brink W; Breeksema JJ; Vermetten E; Schoevers RA
    Tijdschr Psychiatr; 2020; 62(8):650-658. PubMed ID: 32816293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Classic Psychedelics in Addiction Treatment: The Case for Psilocybin in Tobacco Smoking Cessation.
    Johnson MW
    Curr Top Behav Neurosci; 2022; 56():213-227. PubMed ID: 35704271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Psychedelics in the treatment of depression, anxiety, and obsessive-compulsive disorder].
    Breeksema JJ; van den Brink W; Veraart JKE; Smith-Apeldoorn SY; Vermetten E; Schoevers RA
    Tijdschr Psychiatr; 2020; 62(8):618-628. PubMed ID: 32816290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treating Addiction: Perspectives from EEG and Imaging Studies on Psychedelics.
    Tófoli LF; de Araujo DB
    Int Rev Neurobiol; 2016; 129():157-85. PubMed ID: 27503452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Psychedelics in the treatment of PTSD].
    Vermetten E; Krediet E; Bostoen T; Breeksema JJ; Schoevers RA; van den Brink W
    Tijdschr Psychiatr; 2020; 62(8):640-649. PubMed ID: 32816292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Using Psychedelics in Clinical Practice: Comparing Therapeutic Uses and Potential Harms.
    Tariq R
    Curr Rev Clin Exp Pharmacol; 2023; 18(2):94-109. PubMed ID: 35319407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Psychedelics for existential distress in terminally ill patients].
    Schimmel N; Breeksema JJ; Veraart JKE; van den Brink W; Schoevers RA
    Tijdschr Psychiatr; 2020; 62(8):659-668. PubMed ID: 32816294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Efficacy of psychedelics in psychiatry, a systematic review of the literature].
    Berkovitch L; Roméo B; Karila L; Gaillard R; Benyamina A
    Encephale; 2021 Aug; 47(4):376-387. PubMed ID: 33888297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Self-Entropic Broadening Theory: Toward a New Understanding of Self and Behavior Change Informed by Psychedelics and Psychosis.
    Dourron HM; Strauss C; Hendricks PS
    Pharmacol Rev; 2022 Oct; 74(4):982-1027. PubMed ID: 36113878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Classical Psychedelics as Therapeutics in Psychiatry - Current Clinical Evidence and Potential Therapeutic Mechanisms in Substance Use and Mood Disorders.
    Mertens LJ; Preller KH
    Pharmacopsychiatry; 2021 Jul; 54(4):176-190. PubMed ID: 33472250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Neurotrophic mechanisms of psychedelic therapy].
    Corne R; Mongeau R
    Biol Aujourdhui; 2019; 213(3-4):121-129. PubMed ID: 31829932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Psychotherapy assisted by psychedelics, intense and unusual exposures therapy].
    Thorens G; Zullino D
    Rev Med Suisse; 2020 Sep; 16(707):1748-1750. PubMed ID: 32969611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psychedelics as an emerging novel intervention in the treatment of substance use disorder: a review.
    DiVito AJ; Leger RF
    Mol Biol Rep; 2020 Dec; 47(12):9791-9799. PubMed ID: 33231817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Introduction to 'beneficial effects of psychedelics with a special focus on addictions'.
    Breeksema JJ; Kortekaas R
    Curr Drug Abuse Rev; 2014; 7(3):135. PubMed ID: 25870868
    [No Abstract]   [Full Text] [Related]  

  • 15. The History of Psychedelics in Psychiatry.
    Nichols DE; Walter H
    Pharmacopsychiatry; 2021 Jul; 54(4):151-166. PubMed ID: 33285579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psychedelics for the treatment of depression, anxiety, and existential distress in patients with a terminal illness: a systematic review.
    Schimmers N; Breeksema JJ; Smith-Apeldoorn SY; Veraart J; van den Brink W; Schoevers RA
    Psychopharmacology (Berl); 2022 Jan; 239(1):15-33. PubMed ID: 34812901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Switching antipsychotic medication to reduce sexual dysfunction in people with psychosis: the REMEDY RCT.
    Crawford MJ; Thana L; Evans R; Carne A; O'Connell L; Claringbold A; Saravanamuthu A; Case R; Munjiza J; Jayacodi S; Reilly JG; Hughes E; Hoare Z; Barrett B; Leeson VC; Paton C; Keown P; Pappa S; Green C; Barnes TR
    Health Technol Assess; 2020 Sep; 24(44):1-54. PubMed ID: 32930090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The influence of substance use on the effectiveness of antipsychotic medication: a prospective, pragmatic study.
    Alisauskiene R; Løberg EM; Gjestad R; Kroken RA; Jørgensen HA; Johnsen E
    Nord J Psychiatry; 2019; 73(4-5):281-287. PubMed ID: 31140342
    [No Abstract]   [Full Text] [Related]  

  • 19. Ketamine for the treatment of addiction: Evidence and potential mechanisms.
    Ivan Ezquerra-Romano I; Lawn W; Krupitsky E; Morgan CJA
    Neuropharmacology; 2018 Nov; 142():72-82. PubMed ID: 29339294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Psychedelics and mental health: a population study.
    Krebs TS; Johansen PØ
    PLoS One; 2013; 8(8):e63972. PubMed ID: 23976938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.